Skip to content

A Deep Learning Model to Predict Breast Cancer Recurrence Using Longitudinal Mammograms and Clinical Data.

Sep 2026 · Radiology: Artificial Intelligence · pp. e250941 · 0 citations
Medicine

TL;DR

The proposed multimodal deep learning framework improves both recurrence prediction and recurrence subtype discrimination over existing models.

Abstract

Purpose To develop a deep learning model that integrates longitudinal mammograms and static clinical data for predicting the recurrence risk and recurrence subtype of breast cancer. Materials and Methods In this retrospective study, the data of patients examined via imaging from January 2004 to December 2020 were included. A multimodal deep learning model incorporating pretreatment mammographic features and clinical data were developed. A multitask framework was implemented to jointly predict recurrence occurrence (binary classification) and recurrence subtype (local/regional/distant). The model was trained and evaluated within a single institutional cohort. Results A total of 3,923 patients and 19,684 examinations (mean age ± SD, 52.98 years ± 10.98; 3923 female) were included. In the test cohort, the model achieved an area under the receiver operating characteristic curve (AUC) of 0.80 (95% CI: 0.74, 0.85) and an area under the precision-recall curve (AUPRC) of 0.537 (95% CI: 0.432, 0.638) for overall recurrence, outperforming unimodal approaches. For recurrence subtype prediction among recurrencepositive patients, the model achieved a balanced accuracy of 65.1% (95% CI: 60.2%, 71.1%) and an AUC of 0.72 (95% CI: 0.68, 0.78). Conclusion The proposed multimodal deep learning framework improves both recurrence prediction and recurrence subtype discrimination over existing models. ©RSNA, 2026.

View source

Similar papers

Conference Open access 2026

Predicting breast cancer recurrence using multimodal deep learning and MRI: Systematic review

This paper presents a systematic review of deep learning approaches for predicting breast cancer recurrence from multimodal Magnetic Resonance Imaging and clinicopathological data, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.

Ahlam Ait Yahia, Ichrak Khoulqi, N. Idrissi · 0 citations
Open access Sep 2026

Deep Learning-Based Multi-Cancer Analysis for Predicting Disease-Free Survival Across Multiple Cancer Types

The deep learning-based multi-cancer disease-free survival model performed robustly across cancer subtypes, with the nomogram improving risk stratification, particularly for stage I malignancies, complementing existing staging.

Si-Teng Chen, En-Cheng Zhang, Fu-Kang Sun et al. · 0 citations
Open access Sep 2026

A Nomogram Integrating Deep Learning and Immunoscore for Predicting Distant Metastasis and Prognosis in Rectal Cancer.

RATIONALE AND OBJECTIVES To evaluate the performance of nomogram integrating MRI-based deep learning (DL) and immunoscore (IS) for predicting distant metastasis (DM) and prognostic stratification in rectal cancer (RC). MATERIALS AND METHODS This retrospective single-center study included 306 RC patients (mean age, 59...

Hao Jiang, Miao Sun, Wei Guo et al. · 0 citations
#diffusion models Open access Sep 2026

Deep learning radiomics based on preoperative multiparametric MRI in predicting breast cancer recurrence risk

The DLRC model effectively predicted and stratified breast cancer recurrence risk by integrating deep learning, radiomics, and clinicopathological features and achieved the best performance in the training and internal validation sets.

Xin-Miao Gong, Ke-Pei Xu, Mei-Qi Hua et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.